Get started
RocketTickers

FDA Approves Repatha® (evolocumab) In Pediatric Patients Age 10

Long
Amgen Inc. (NASDAQ:AMGN)  
RocketTickers  
NASDAQ:AMGN   Amgen Inc.
Beyond Technical Analysis
0
0
beyondta
AMGN: Amgen
2021-09-25 20:00:00
FDA Approves Repatha® (evolocumab) In Pediatric Patients Age 10 And Older With Heterozygous Familial Hypercholesterolemia
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.